Track topics on Twitter Track topics that are important to you
As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will close or sell six production facilities before the end of in 2017, followed by nine in 2018. It will also pull back from 45 countries by the end of this year.
Original Article: Teva Cuts Jobs, Closes Plants as Woes DeepenNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...